Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

The trial, which involved more than 8,000 adults 50 and older, found that antibody levels generated by the new vaccine were about 20% to 40% higher than getting the shots apart, with the exception of ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing. Influenza causes 140,000 to ...

Scientists are testing and working on the world’s first acne vaccine, hoping to offer a long-term alternative to current ...

Its mRNA technology could allow the firm to compete ... The convenience of a combination shot could draw some of the 150 million Americans who receive a flu shot each year to receive Moderna's ...

Moderna's mRNA Covid vaccine is one of two mRNA vaccines currently available in the U.S. (Sholten Singer / The Herald-Dispatch via AP fil) ...

Moderna conducted a study to test a combination COVID-19 and flu shot. Researchers tested the shot on 8,000 adults. The pharmaceutical and biotechnology company is targeting 2026 for approval of ...